Published in Postgrad Med J on November 01, 1985
Iron absorption and loading in beta-thalassaemia intermedia. Lancet (1979) 1.66
Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis. Am J Pathol (1954) 1.59
Changes of trace minerals (serum iron, zinc, copper and magnesium) in thalassemia. Acta Haematol (1975) 1.47
Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. Am J Med (1967) 1.47
Hormonal changes in thalassaemia major. Arch Dis Child (1976) 1.36
Importance of the hematocrit in interpretation of blood sugar. Diabetes (1965) 1.17
Pancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr (1977) 1.10
Endocrine assessment of hypogonadism in patients affected by thalassaemia major. Ric Clin Lab (1981) 1.00
Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Arch Dis Child (1983) 0.99
Abnormal glucose tolerance in beta-thalassemia major. Metabolism (1977) 0.95
Inhibition of insulin secretion by a phaeochromocytoma. Lancet (1966) 0.93
Carbohydrate homeostasis and pancreatic islet cell funtion in thalassemia. Ann Intern Med (1974) 0.91
Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major. Diabetes (1977) 0.89
Influence of age and sex on plasma zinc levels in normal and diabetic individuals. Nutr Metab (1976) 0.84
Urinary vanillyl-mandelic acid (VMA) excretion by chronically anaemic children. Arch Dis Child (1968) 0.83
Endocrine function in thalassaemia. Clin Endocrinol (Oxf) (1981) 0.80
[Relations between hypothalamo-hypophyseal-gonadal function and hemoglobin level in the polytransfused thalassemic child]. Minerva Pediatr (1981) 0.79
Beta-cell function assessed by plasma C-peptide evaluation in diabetic thalassaemic patients. Helv Paediatr Acta (1983) 0.78
Glucose tolerance and chelation therapy in patients with thalassaemia major. Haematologica (1983) 0.77
[The integration of nuclear medicine methods into cardiology: an operative proposal]. G Ital Cardiol (1992) 2.68
Survival and complications in thalassemia. Ann N Y Acad Sci (2005) 2.25
Survival and disease complications in thalassemia major. Ann N Y Acad Sci (1998) 1.62
Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose. Eur J Nucl Med (1997) 1.42
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects. Cardiology (1989) 1.42
Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy. Acta Anaesthesiol Scand (2007) 1.42
Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr (1992) 1.40
Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child (1991) 1.39
Safety profile of the oral iron chelator deferiprone: a multicentre study. Br J Haematol (2000) 1.32
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol (2008) 1.27
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. Br J Haematol (2000) 1.26
Did malaria select for primary adult lactase deficiency? Gut (1994) 1.19
Growth and sexual maturation in thalassemia major. J Pediatr (1985) 1.16
Screening for beta-thalassaemia heterozygotes. Lancet (1980) 1.15
Reproductive compensation in families segregating for Cooley's anaemia in Ferrara. Ann Hum Genet (1978) 1.14
Assessment of prospective genetic counseling in the Ferrara area. Am J Med Genet (1980) 1.12
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation. Eur J Nucl Med (1998) 1.11
Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta Haematol (1992) 1.09
Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab (2000) 1.07
New anti-beta-lipoprotein sera in transfused children with thalassemia. Vox Sang (1967) 1.05
Endocrine abnormalities in thalassemia. Ann N Y Acad Sci (1990) 1.02
Growth hormone deficiency in adults with thalassemia: an overview and the I-CET recommendations. Georgian Med News (2013) 1.02
Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol (1997) 1.01
Endocrine assessment of hypogonadism in patients affected by thalassaemia major. Ric Clin Lab (1981) 1.00
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer. Br J Cancer (2011) 1.00
Appearance of beta globin synthesis in erythroid cells of Ferrara beta -o-thalassaemic patients following blood transfusion. Nature (1975) 1.00
Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia. J Am Acad Dermatol (2001) 0.99
Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Arch Dis Child (1983) 0.99
Antioxidant capacity in seminal plasma of transfusion-dependent beta-thalassemic patients. Exp Clin Endocrinol Diabetes (2004) 0.97
Induction of spermatogenesis in thalassaemia. Fertil Steril (1988) 0.97
A two-locus model for non-syndromic congenital dysplasia of the hip (CDH). Ann Hum Genet (2000) 0.96
Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr (1996) 0.96
Screening for developmental dysplasia of the hip: from theory to practice. Collaborative Group DDH Project. Pediatrics (1997) 0.94
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med (1998) 0.93
Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab (1998) 0.93
Genetic counselling in beta thalassemia in Ferrara. J Genet Hum (1980) 0.92
Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J Neurooncol (2008) 0.92
Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab (2003) 0.91
Right ventricular failure: physiology and assessment. Minerva Anestesiol (2005) 0.90
Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection. Clin Exp Immunol (1984) 0.89
Gonadal function in patients with beta thalassaemia major. J Clin Pathol (1988) 0.89
Final height and endocrine function in thalassaemia intermedia. J Pediatr Endocrinol Metab (1998) 0.89
A study of nine polymorphic systems in the population of the Po Delta. Am J Phys Anthropol (1976) 0.89
The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients. Postgrad Med J (1986) 0.88
Haemoglobin levels and blood requirement in thalassaemia. Arch Dis Child (1982) 0.88
The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomas. Tumori (1997) 0.88
Low red blood cell glutathione reductase and pyridoxine phosphate oxidase activities not related to dietary riboflavin: selection by malaria? Am J Clin Nutr (1993) 0.88
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J Hypertens (1990) 0.87
[Immunoelectrophoretic study of the plasma proteins in children with Cooley's disease]. Riv Clin Pediatr (1966) 0.87
Psychosocial integration of adolescents and young adults with thalassemia major. Ann N Y Acad Sci (1998) 0.87
The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints. Eur J Obstet Gynecol Reprod Biol (1994) 0.87
Peripheral quantitative Computed Tomography (PQCT) in the evaluation of bone geometry, biomechanics and mineral density in postmenopausal women. Radiol Med (2002) 0.86
Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy. Gynecol Obstet Invest (1986) 0.85
Hypothalamic-pituitary-gonadal axis in thalassemic patients with secondary amenorrhea. Obstet Gynecol (1988) 0.84
Osteoporosis in beta-thalassemia: Clinical and genetic aspects. Ann N Y Acad Sci (2005) 0.84
Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic patients: evidence of an impaired prostatic function. Exp Clin Endocrinol Diabetes (1997) 0.83
Short-term effect of oophorectomy on lipoprotein metabolism. Gynecol Obstet Invest (1984) 0.83
Genetic and other influences on red-cell flavin enzymes, pyridoxine phosphate oxidase and glutathione reductase in families with beta-thalassaemia. Eur J Haematol (1989) 0.83
Biological performance in beta-thal heterozygotes and normals: results of a longitudinal comparison in a former malarial environment. Ann Hum Genet (1987) 0.83
Correlation of MAST chemiluminescent assay (CLA) with RAST and skin prick tests for diagnosis of inhalant allergic disease. Ann Allergy (1989) 0.83
[Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology]. Radiol Med (1988) 0.82
Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol (2001) 0.82
Current guidelines for the management of aggressive non-Hodgkin's lymphoma. Drugs (1997) 0.82
Comparative evaluation of RAST and MAST-CLA for six allergens for the diagnosis of inhalant allergic disease in 232 patients. Clin Exp Allergy (1992) 0.82
Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major. Clin Endocrinol (Oxf) (1994) 0.82
MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol (1998) 0.82
Changes in superoxide anion production in neutrophils from multitransfused beta-thalassemia patients: correlation with ferritin levels and liver damage. Acta Haematol (1984) 0.81
Reproductive behaviour of families segregating for Cooley's anaemia before and after the availability of prenatal diagnosis. J Med Genet (1991) 0.81
A simple and semi-automated system for increasing the recovery of aqueous [18F] fluoride from target. Anticancer Res (1998) 0.81
[Use of technetium in thyroid scintigraphy]. Minerva Radiol (1969) 0.80
Red-cell GSH regeneration and glutathione reductase activity in G6PD variants in the Ferrara area. Br J Haematol (1987) 0.80
Haplotypes of thalassaemic families from the Po river delta: importance for prenatal diagnosis of beta-thalassaemia. Eur J Haematol (1988) 0.80
Induction of humoral autoimmune response to rat male accessory glands. Medicina (B Aires) (1981) 0.80
Influence of estrogens on serum free fatty acid levels in women. J Clin Endocrinol Metab (1990) 0.80
Glutathione reductase activity and its relationship to pyridoxine phosphate activity in G6PD deficiency. Eur J Haematol (1987) 0.80
Ferrara beta 0 thalassaemia caused by the beta 39 nonsense mutation. Nature (1984) 0.80
Pancreatic beta-cell function before and after bone marrow transplantation for thalassemia. Bone Marrow Transplant (1993) 0.80
Isoantibodies to inherited types of beta-lipoproteins (Ag) and immunoglobulins (Gm and Inv). Serological and clinical aspects. J Pediatr (1968) 0.80
Reproductive behavior of thalassemic couples segregating for Cooley anemia. Am J Med Genet (1991) 0.80
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J Hypertens (1992) 0.80
Organization of alpha-globin genes and mRNA translation in subjects carrying haemoglobin Hasharon (alpha 47 Asp replaced by His) from the Ferrara Region (Northern Italy). Eur J Biochem (1980) 0.80